Clin Asst Prof Lee Suat Ying

Dr Lee Suat Ying graduated from NUS Yong Loo Lin School of Medicine in 2013, and went on to complete her Internal Medicine Junior Residency in Singhealth. She subsequently completed her Senior Residency in Medical Oncology in 2020 and has been practicing in the National Cancer Centre Singapore since as a member of the Gastrointestinal Oncology group. Her area of clinical and research interest is in gastrointestinal cancers, particularly hepatopancreatobiliary cancers.

• ​Completed Senior Residency in Medical Oncology in SHS in 2020
• Obtained MRCP (UK) in 2016
• Completed Junior Residency in Internal Medicine in SHS in 2016
• Graduated in 2013 with MBBS from NUS YLLSoM

• Core Faculty Member, Singhealth Medical Oncology Residency Programme
• SSO member
• ASCO member
• ESMO member

• 2026: Singhealth Health Manpower Development Plan Award
• 2024: Outstanding Faculty Award
• ​2017: Outstanding Senior Resident (RISE award)  

• Lee SY, Lim CW, Kim S, Majeed UBA, Ng KYY, Chang JP, Tai DW, Yoo C, Lee JJX. Using the EVendo Score to Predict Varices and Varices Needing Treatment in Hepatocellular Carcinoma Patients Planned for Atezolizumab-Bevacizumab. Dig Dis Sci. 2026 Feb 26. doi: 10.1007/s10620-026-09776-y. Epub ahead of print. PMID: 41741892.
• Kim S, Lee SY (joint first author), Cheon J, Kim HD, Park YG, Lee JJX, Ryu MH, Ryoo BY, Tai D, Yoo C. Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific. Target Oncol. 2024 Nov;19(6):917-923. doi: 10.1007/s11523-024-01103-7. Epub 2024 Oct 3. PMID: 39361219.
• Han, S.; Lee, S.Y (joint first author); Wang, W.-W.; Tan, Y.B.; Sim, R.H.Z.; Cheong, R.; Tan, C.; Hopkins, R.; Connolly, J.; Shuen, W.H.; Toh, H.C. A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs). Cancers 2020, 12, 3404. https://doi.org/10.3390/cancers12113404
• Yuen J, Lee SY (joint first author), Courtney E, Lim J, Soh H, Li ST, et al. Evaluating empowerment in genetic counseling using patient-reported outcomes. Clin Genet. (2020) 97:246–56. doi: 10.1111/cge.13646
• Chan AHY, Zhao Y, Tan HL, Chua DW, Ng KYY, Lee SY, Lee JJX, Tai D, Goh BKP, Koh YX. Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and Meta-analysis of Latest Randomized Controlled Trials. Ann Surg Oncol. 2025 Jun;32(6):4094-4107. doi: 10.1245/s10434-024-16674-y. Epub 2025 Feb 22. PMID: 39987384. [IF: 3.5]
• Ng KYY, Teo AEK, Tan SH, Tan JJE, Tay DSH, Lee AWX, Ang AJS, Wong LWJ, Choo SP, Toh HC, Lee SY, Lee JJX, Tai DW. Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma. Asia Pac J Clin Oncol. 2025 Jun;21(3):256-265. doi: 10.1111/ajco.14139. Epub 2024 Nov 27. PMID: 39601254. [IF: 1.6]
• Tan HL, Zhao Y, Chua DW, Ng KYY, Lee SY, Lee JJX, Tai DW, Goh BKP, Koh YX. Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomized controlled trials. Surgery. 2025 Dec 10:109872. doi: 10.1016/j.surg.2025.109872. Epub ahead of print. PMID: 41381268. [IF: 2.7]
• Liew SZH, Ng KW, Ishak NDB, Lee SY, Zhang Z, Chiang J, Ngeow JYY. Geographical, ethnic, and genetic differences in pancreatic cancer predisposition. Chin Clin Oncol. 2023 Jun;12(3):27. doi: 10.21037/cco-23-8. PMID: 37417291.
• Yang SP, Ying LS, Saw S, Tuttle RM, Venkataraman K, Su-Ynn C. Practical Barriers to Implementation of Thyroid Cancer Guidelines in the Asia-Pacific Region. Endocr Pract. 2015 Nov;21(11):1255-68. doi: 10.4158/EP15850